Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2080

1.

Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.

Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Ravaioli M, Zanello M, Andreone P, Capussotti L, Pinna AD.

Arch Surg. 2009 Oct;144(10):906-13. doi: 10.1001/archsurg.2009.99.

PMID:
19841357
2.
3.

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.

Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME.

Ann Surg Oncol. 2000 Dec;7(10):764-70.

PMID:
11129425
6.

[Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection].

Li HK, Qin Y, Li XM, Li Q.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):426-8. Chinese.

PMID:
19567020
7.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109
8.

Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.

Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.

Liver Int. 2005 Apr;25(2):236-41.

PMID:
15780044
9.

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.

Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E; European Concerted Action on Viral Hepatitis (EUROHEP).

Am J Gastroenterol. 2002 Nov;97(11):2886-95.

PMID:
12425564
10.

Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?

Moya A, Berenguer M, Aguilera V, Juan FS, Nicolás D, Pastor M, López-Andujar R, Rayón M, Orbis F, Mora J, De Juan M, Carrasco D, Vila JJ, Prieto M, Berenguer J, Mir J.

Liver Transpl. 2002 Nov;8(11):1020-7.

11.

Viral serostatus and coexisting inflammatory activity affect metachronous carcinogenesis after hepatectomy for hepatocellular carcinoma. A further report.

Yamanaka N, Takada M, Tanaka T, Yamanaka J, Yasui C, Ando T, Maeda S, Matsushita K, Okamoto E.

J Gastroenterol. 2000;35(3):206-13.

PMID:
10755690
12.

Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.

Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.

Liver Transpl. 2007 Jun;13(6):807-13.

13.

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.

Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A.

Cancer. 1994 Nov 1;74(9):2442-8.

PMID:
7922998
14.

Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival.

Zhang XF, Meng B, Qi X, Yu L, Liu C, Liu XM, Wang B, Pan CE, Lv Y.

Eur J Surg Oncol. 2009 Jun;35(6):622-8. doi: 10.1016/j.ejso.2008.08.003. Epub 2008 Oct 2.

PMID:
18835514
15.

Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?

Huo TI, Huang YH, Hsia CY, Su CW, Lin HC, Hsu CY, Lee PC, Lui WY, Loong CC, Chiang JH, Chiou YY, Lee SD.

Liver Int. 2009 May;29(5):767-73. doi: 10.1111/j.1478-3231.2008.01908.x. Epub 2008 Nov 3.

PMID:
19018974
16.

Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.

Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.

Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.

PMID:
18584524
17.

Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection.

Huo TI, Wu JC, Lui WY, Lee PC, Huang YH, Chau GY, Tsay SH, Chang FY, Lee SD.

Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1203-8.

PMID:
14560154
18.

Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.

Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.

Liver Transpl. 2004 Dec;10(12):1478-86.

19.

Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.

Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW.

Liver Transpl. 2009 Nov;15(11):1525-34. doi: 10.1002/lt.21882.

20.

Supplemental Content

Support Center